Home
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2383-0298
eISSN
:
2383-0301
Submit Your Paper
Instructions for Authors
Journal Information
Aims and Scope
Editorial Board
Publication Ethics
Editorial policies
Peer Review
Open Access
Archive
Indexing Information
Listed in:
Follower of
Officially associated with
Iranian Society of Microbiology
Infectious Disease Research Center
,UMSHA
Avicenna J Clin Microbiol Infect
. 2016;3(2): 36521. doi:
10.17795/ajcmi-36521
Research Article
Prevalence of
A2143G
and
A2144G
Point Mutations Responsible for Clarithromycin Resistance among
Helicobacter pylori
Strains in Bushehr, Iran
Saeed Tajbakhsh
1
,
2
* , Jamal Falahi
1
, Niloofar Motamed
3
, Seyed Masoud Tabib
4
, Abbas Bahador
5
, Somayyeh Gharibi
2
Cited by CrossRef: 4
1- Khademi F, Sahebkar A, Vaez H, Arzanlou M, Peeridogaheh H. Characterization of clarithromycin-resistant Helicobacter pylori strains in Iran: A systematic review and meta-analysis.
Journal of Global Antimicrobial Resistance
. 2017;10:171
[Crossref]
2- Matta A, Zambrano D, Pazos A. Punctual mutations in23S rRNAgene of clarithromycin-resistantHelicobacter pyloriin Colombian populations.
WJG
. 2018;24(14):1531
[Crossref]
3- Vazirzadeh J, Falahi J, Moghim S, Narimani T, Rafiei R, Karbasizadeh V, Galani V. Molecular Assessment of Resistance to Clarithromycin in Helicobacter pylori Strains Isolated from Patients with Dyspepsia by Fluorescent In Situ Hybridization in the Center of Iran.
BioMed Research International
. 2020;2020(1)
[Crossref]
4- Khan S, Sharaf M, Ahmed I, Khan T, Shabana S, Arif M, Kazmi S, Liu C. Potential utility of nano-based treatment approaches to address the risk ofHelicobacter pylori.
Expert Review of Anti-infective Therapy
. 2022;20(3):407
[Crossref]
